Stereotaxis (STXS) Cash from Investing Activities Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -53.20% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 15.82% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -27.34% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 19.58% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 3.16% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -35.55% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 7.86% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 9.96% |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn | 39.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.06% |
| Dec 31, 2025 | 84.84% |
| Dec 31, 2024 | 88.13% |
| Sep 30, 2024 | 57.70% |
| Dec 31, 2022 | -1,037.29% |
| Sep 30, 2022 | -224.51% |
| Mar 31, 2022 | -389.60% |
| Dec 31, 2021 | -393.88% |
| Sep 30, 2021 | 36.45% |
| Jun 30, 2021 | -35.26% |
| Mar 31, 2021 | -50.42% |
| Dec 31, 2018 | 52.63% |
| Sep 30, 2018 | -200.01% |
| Mar 31, 2018 | 42.45% |
| Dec 31, 2017 | 50.07% |
| Sep 30, 2017 | -118.48% |
| Dec 31, 2015 | -439.11% |
| Sep 30, 2015 | 24.46% |
| Mar 31, 2015 | 13.96% |
| Dec 31, 2014 | -9.02% |
| Sep 30, 2014 | 73.70% |